Anthony Robert Rees
Président chez SpinChem AB
Profil
Anthony Robert Rees is the founder of Oxford Molecular Group Plc, Sulis Innovation Ltd.
He currently serves as the Chairman of SpinChem AB.
He previously served as the Chief Executive Officer of MIP Technologies AB, Chairman-Supervisory Board of F-Star Biotechnologische Forschungs-.
Und Entwicklungsges MBH, Director of BioVeris Corp.
and IGEN International, Inc., Head-Biochemistry at the University of Bath, and Chief Scientific Officer of Biotage AB.
He holds a doctorate degree from the University of Oxford.
Postes actifs de Anthony Robert Rees
| Sociétés | Poste | Début |
|---|---|---|
SpinChem AB
 SpinChem AB Industrial ConglomeratesProducer Manufacturing SpinChem AB engages in the development, manufacture, and sale of products for chemical synthesis. It offers SpinChem, an innovative concept for mass transfer enhancement in reactions involving solid phase reagents, encompassing several different ways of using the stirring element itself to establish a forced flow through a heterogeneous reactant or catalyst bed, which is located inside the stirrer body. The company was founded by Fredrik Almqvist and Kjell Robert Öberg in 2007 and is headquartered in Umea, Sweden. | Président | - |
Anciens postes connus de Anthony Robert Rees
| Sociétés | Poste | Fin |
|---|---|---|
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
 F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Président | 14/05/2012 |
IGEN International, Inc.
 IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Directeur/Membre du Conseil | 08/04/2011 |
BioVeris Corp.
 BioVeris Corp. BiotechnologyHealth Technology BioVeris Corp. developed and manufactured diagnostic products. It operates as a global health care and biosecurity company that developing proprietary technologies in diagnostics and vaccinology. The firm specializes in electrochemiluminescence and immunochemistry. The company was founded in 2003 and is headquartered in Gaithersburg, MD. | Directeur/Membre du Conseil | 28/06/2007 |
| University of Bath | Corporate Officer/Principal | 01/01/1993 |
| BIOTAGE AB | Directeur Technique/Scientifique/R&D | - |
Formation de Anthony Robert Rees
| University of Oxford | Doctorate Degree |
Expériences
Fonctions occupées
Actives
Inactives
Sociétés cotées
Entreprise privées
Relations
Relations au 1er degré
Entreprises liées au 1er degré
Homme
Femme
Administrateurs
Exécutifs
Sociétés liées
| Sociétés cotées | 1 |
|---|---|
| BIOTAGE AB | Health Technology |
| Entreprise privées | 7 |
|---|---|
BioVeris Corp.
BioVeris Corp. BiotechnologyHealth Technology BioVeris Corp. developed and manufactured diagnostic products. It operates as a global health care and biosecurity company that developing proprietary technologies in diagnostics and vaccinology. The firm specializes in electrochemiluminescence and immunochemistry. The company was founded in 2003 and is headquartered in Gaithersburg, MD. | Health Technology |
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH
F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH Medical SpecialtiesHealth Technology F-Star Biotechnologische Forschungs- Und Entwicklungsges MBH develops improved therapeutic antibodies and antibody fragments for cancer. It is a biopharmaceutical company dedicated to developing novel bispecific antibody products that significantly improve on the current standard of care for patients with serious diseases such as cancer. The firm's modular antibody technology allows them to rapidly discover and develop bispecific antibodies by introducing additional binding sites to the constant region of an antibody. The company was founded by Florian Ruker, Gordana Wozniak-Knopp, and Gottfried Himmler on June 12, 2006 and is headquartered in Vienna, Austria. | Health Technology |
| Oxford Molecular Group Plc | Health Technology |
IGEN International, Inc.
IGEN International, Inc. Medical SpecialtiesHealth Technology IGEN International, Inc. develops and markets biological testing systems that incorporate its proprietary electrochemiluminescence technology for used in drug discovery, diagnostic products development as well as food and environmental safety testing. The company was founded in 1982 and is headquartered in Gaithersburg, MD. | Health Technology |
| Sulis Innovation Ltd. | |
MIP Technologies AB
 MIP Technologies AB Miscellaneous Commercial ServicesCommercial Services MIP Technologies is a biotechnology company working at the boundary of chemistry and materials science. The company develops solutions in the Separations field using proprietary Molecularly Imprinted Polymer (MIP) technology and other novel polymer chemistries. Its pipeline of solid phase extraction (SPE) phases, based on molecular imprinting and marketed under the Supelco Sigma Aldrich brand name, SupelMIP, provides clever solutions to difficult analytical extraction problems. Its custom OPUS phases which use both molecular imprinting and smart variations of conventional polymer chemistry, provide unmatched preparative and process scale separation solutions for both small molecules and peptides. | Commercial Services |
SpinChem AB
SpinChem AB Industrial ConglomeratesProducer Manufacturing SpinChem AB engages in the development, manufacture, and sale of products for chemical synthesis. It offers SpinChem, an innovative concept for mass transfer enhancement in reactions involving solid phase reagents, encompassing several different ways of using the stirring element itself to establish a forced flow through a heterogeneous reactant or catalyst bed, which is located inside the stirrer body. The company was founded by Fredrik Almqvist and Kjell Robert Öberg in 2007 and is headquartered in Umea, Sweden. | Producer Manufacturing |
